glucosamine/Finding
One finding, on its own
A single claim from the graph, with the evidence strength computed from its study, the sentence it was drawn from, and the paper. This address does not change.
Decreases osteoarthritis pain (pooled across scales)
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.Findingreplicated ×1“Glucosamine moderately reduced pain (SMD -0.51 [95% CI -0.72, -0.30]), although a high level of between-trial inconsistency was observed (I(2) = 88%).”
Quoted verbatim from Risk of bias and brand explain the observed inconsistency in trials on glucosamine for symptomatic relief of osteoarthritis: a meta-analysis of placebo-controlled trials.. - Study
- meta-analysis
- Population
- Osteoarthritis patients, pooled across 25 placebo-controlled glucosamine trials
Effect -0.51 standardised mean difference, 95% CI -0.72 to -0.3
Risk of bias and brand explain the observed inconsistency in trials on glucosamine for symptomatic relief of osteoarthritis: a meta-analysis of placebo-controlled trials.2014PMID:24905534Permalink
Keep reading
- Everything the graph holds on glucosamine
- Every compound studied against Osteoarthritis pain (pooled across scales)
- How to read the evidence strength and the marks
To cite this finding: https://catalystproject.ai/e/01M1Z4T6N7RKJH86DS8A6ECZBF